These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Double-blind comparison of metaproterenol and isoetharine-phenylephrine solutions in intermittent positive pressure breathing in bronchospastic conditions. Riker JB; Cacace LG Chest; 1980 Nov; 78(5):723-5. PubMed ID: 7000452 [TBL] [Abstract][Full Text] [Related]
3. Double-blind, dose-response study of metaproterenol inhalant solution in children with acute asthma. Shapiro GG; Furukawa CT; Pierson WE; Chapko MK; Sharpe M; Bierman CW J Allergy Clin Immunol; 1987 Feb; 79(2):378-86. PubMed ID: 3546466 [TBL] [Abstract][Full Text] [Related]
4. Dose-related effects of nebulized metaproterenol in asthmatic children. Crain EF; Gershel JC; Kadar A; Kastner T Pediatr Emerg Care; 1987 Sep; 3(3):143-6. PubMed ID: 3671137 [TBL] [Abstract][Full Text] [Related]
5. Long-term metaproterenol therapy in asthmatic children. Brandon ML JAMA; 1976 Feb; 235(7):736-7. PubMed ID: 765528 [TBL] [Abstract][Full Text] [Related]
6. Aerosolized metaproterenol in the treatment of asthmatics with severe airflow obstruction. Comparison of two delivery methods. Salzman GA; Steele MT; Pribble JP; Elenbaas RM; Pyszczynski DR Chest; 1989 May; 95(5):1017-20. PubMed ID: 2707058 [TBL] [Abstract][Full Text] [Related]
7. Metaproterenol solution in the treatment of asthmatic patients by intermittent positive pressure breathing. Branscomb BV J Clin Pharmacol; 1982; 22(5-6):231-5. PubMed ID: 7050188 [TBL] [Abstract][Full Text] [Related]